Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Liability in desensitization accidents].

G Bauer1

  • 1Institut für Gerichtliche Medizin, Universität Wien, Osterreich.

Zeitschrift Fur Rechtsmedizin. Journal of Legal Medicine
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for excited and exotic electrons in the egamma decay channel in pp collisions at sqrt[s] = 1.96 TeV.

Physical review letters·2005
Same author

Measurement of the lifetime difference between Bs mass eigenstates.

Physical review letters·2005
Same author

Measurement of Wgamma and Zgamma production in pp collisions at square root s=1.96 TeV.

Physical review letters·2005
Same author

First measurements of inclusive W and Z cross sections from run II of the fermilab tevatron collider.

Physical review letters·2005
Same author

Search for doubly charged Higgs bosons decaying to dileptons in pp collisions at square root of s=1.96 TeV.

Physical review letters·2004
Same author

Inclusive double-pomeron exchange at the fermilab tevatron p p collider.

Physical review letters·2004
Same journal

[Immunohistochemical C5b-9-complement complex demonstration in early stages of myocardial necroses using paraffin sections].

Zeitschrift fur Rechtsmedizin. Journal of legal medicine·1990
Same journal

[Genetically-induced variability of alcohol metabolism and its effect on drinking behavior and predisposition to alcoholism].

Zeitschrift fur Rechtsmedizin. Journal of legal medicine·1990
Same journal

[Special design characteristics of the Japanese "Tan-to" (knife) as criteria for dangerousness].

Zeitschrift fur Rechtsmedizin. Journal of legal medicine·1990
Same journal

[Changes in skeletal muscles in death caused by hypothermia].

Zeitschrift fur Rechtsmedizin. Journal of legal medicine·1990
Same journal

The extent of aspartic acid racemization in dentin: a possible method for a more accurate determination of age at death?

Zeitschrift fur Rechtsmedizin. Journal of legal medicine·1990
Same journal

Gc in bloodstains.

Zeitschrift fur Rechtsmedizin. Journal of legal medicine·1990
See all related articles

Deaths during desensitization treatment are under legal scrutiny. The study proposes enhanced reporting of mild systemic reactions to improve patient safety and clarify liability for allergenic extract treatments.

Area of Science:

  • Immunology
  • Pharmacology
  • Legal Medicine

Context:

  • Desensitization treatments carry inherent risks, with deaths prompting legal investigations.
  • Proving causality for adverse events linked to allergenic extracts is challenging.
  • Evolving legal standards increasingly favor patients in liability cases against drug producers.

Purpose:

  • To analyze the legal landscape surrounding deaths during desensitization therapy.
  • To discuss product liability and liability for injury in Germany and Austria.
  • To propose improvements in reporting adverse events to enhance patient safety.

Summary:

  • Deaths during desensitization therapy are subject to legal review, with difficulties in attributing incidents to specific allergenic extract activity.

Related Experiment Videos

  • The legal burden of proof is shifting towards patients, necessitating clearer regulations for drug manufacturers.
  • A significant legal gray area exists regarding liability for desensitization treatment incidents.

    • Impact:

    • Recommends intensifying the duty to notify by including mild systemic reactions in a central registry.
    • Aims to improve the safety of allergenic extract treatments.
    • Contributes to the ongoing discussion on pharmaceutical liability and patient protection.